![Wei Chang Zhou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wei Chang Zhou
Direttore/Membro del Consiglio presso WUXI BIOLOGICS (CAYMAN) INC.
Patrimonio netto: 714 532 $ in data 30/06/2024
Posizioni attive di Wei Chang Zhou
Società | Posizione | Inizio | Fine |
---|---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Direttore/Membro del Consiglio | 01/05/2016 | - |
Direttore Tecnico/Scientifico/R&S | 01/11/2016 | 31/03/2024 | |
WUXI XDC CAYMAN INC. | Direttore/Membro del Consiglio | 01/12/2020 | - |
Storia della carriera di Wei Chang Zhou
Precedenti posizioni note di Wei Chang Zhou
Società | Posizione | Inizio | Fine |
---|---|---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/03/2008 | 01/12/2012 |
PDL BIOPHARMA, INC. | Direttore/Membro del Consiglio | 01/10/2002 | 01/02/2008 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/05/1994 | 01/10/2002 |
Formazione di Wei Chang Zhou
Jiangxi University of Science & Technology | Undergraduate Degree |
University of Hannover | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Stati Uniti | 4 |
Germania | 2 |
Posizioni
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
WUXI XDC CAYMAN INC. | Commercial Services |
Aziende private | 2 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
![]() PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Borsa valori
- Insiders
- Wei Chang Zhou
- Esperienza